UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

Clinical gastroenterology and hepatology, 2022-12, Vol.20 (12), p.2858-2867.e5

2022

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease, 2017-09, Vol.14 (5), p.476-483

2017

Volltextzugriff (PDF)

Actuarial valuations to monitor defined benefit pension funding

British Actuarial Journal, 2020-01, Vol.25, Article e14

O’Brien, Christopher D.

2020

Volltextzugriff (PDF)

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Inflammatory bowel diseases, 2021-06, Vol.27 (7), p.994-1007

2021

Volltextzugriff (PDF)

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

American Journal of Physiology: Cell Physiology, 2002-05, Vol.282 (5), p.C1181-C1190

2002

Volltextzugriff (PDF)

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

Current medical research and opinion, 2009-06, Vol.25 (6), p.1563-1571

2009

Volltextzugriff (PDF)

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

British Actuarial Journal, 2024-01, Vol.29, Article e8

O’Brien, Christopher D.

2024

Volltextzugriff (PDF)

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

American Journal of Physiology: Cell Physiology, 2004-10, Vol.287 (4), p.C1103-C1113

2004

Volltextzugriff (PDF)

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

Blood, 2003-04, Vol.101 (7), p.2816-2825

2003

Volltextzugriff (PDF)

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

The Journal of immunology (1950), 2000-01, Vol.164 (1), p.452-462

2000

Volltextzugriff (PDF)

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Crohn's & colitis 360, 2020-10, Vol.2 (4), p.otaa063-otaa063

2020

Volltextzugriff (PDF)

Can Patients With Asthma Feel Inhaler Therapy Working Right Away? Two Clinical Trials Testing the Effect of Timing of Assessment on Patient Perception

The Journal of asthma, 2009-12, Vol.46 (10), p.1006-1012

2009

Volltextzugriff (PDF)

Sa1827 PREGNANCY OUTCOMES IN WOMEN WITH PSORIASIS, PSORIATIC ARTHRITIS, CROHN'S DISEASE AND ULCERATIVE COLITIS TREATED WITH USTEKINUMAB

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-442-S-442

2020

Volltextzugriff (PDF)

Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study

PloS one, 2023-03, Vol.18 (3), p.e0282267-e0282267

2023

Volltextzugriff (PDF)

Availability of the combination of formoterol and budesonide in the United States of America

Allergy and asthma proceedings, 2008-07, Vol.29 (4), p.426-426

2008

Volltextzugriff (PDF)

PECAM-1 (CD31) Regulates a Hydrogen Peroxide-Activated Nonselective Cation Channel in Endothelial Cells

The Journal of cell biology, 2002-04, Vol.157 (1), p.173-184

2002

Volltextzugriff (PDF)

697 Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S408-S409

2019

Volltextzugriff (PDF)

1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-235-S-236

2020

Volltextzugriff (PDF)

615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-131-S-132

2020

Volltextzugriff (PDF)

Tu1851 CORTICOSTEROID SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1187-S-1188

2020

Volltextzugriff (PDF)

Tu1879 EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1201-S-1201

2020

Volltextzugriff (PDF)

Tu1885 EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN BIOLOGIC NAÏVE, BIOLOGIC NON-FAILURE, AND BIOLOGIC FAILURE POPULATIONS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1203-S-1204

2020

Volltextzugriff (PDF)

Tu1886 DOSE ADJUSTMENT IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI MAINTENANCE STUDY LONG-TERM EXTENSION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1204-S-1204

2020

Volltextzugriff (PDF)

International Diversity in Measuring the Fair Value of Life Insurance Contracts

Geneva papers on risk and insurance. Issues and practice, 2009-04, Vol.34 (2), p.197-227

2009

Volltextzugriff (PDF)

Tu1749 – Pharmacokinetics and Exposure-Response Relationships of Intravenously Administered Ustekinumab During Induction Treatment in Patients with Ulcerative Colitis: Results from the Unifi Induction Study

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1110-S-1110

2019

Volltextzugriff (PDF)

1 – 25 von 567

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(486)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(340)
Life Sciences & Biomedicine
(248)
Humans
(156)
Physical Sciences
(69)
Animals
(51)
Biological And Medical Sciences
(51)
Medical Sciences
(44)
Orthopedics
(36)
Chemistry
(27)
Technology
(27)
Adult
(26)
Female
(25)
Neurosciences & Neurology
(25)
Cardiovascular System & Cardiology
(24)
Environmental Sciences & Ecology
(21)
Science & Technology - Other Topics
(21)
Surgery
(21)
Engineering
(20)
Multidisciplinary Sciences
(20)
Cardiac & Cardiovascular Systems
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Spine Journal
(34)
Gastroenterology
(19)
Blood
(13)
Nature
(8)
Nature Communications
(7)
Transplantation
(7)
Journal Of Ultrasound In Medicine
(6)
Science
(6)
Bioorganic & Medicinal Chemistry Letters
(5)
Cheminform
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Actuarial valuations to monitor defined benefit pension funding

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Can Patients With Asthma Feel Inhaler Therapy Working Right Away? Two Clinical Trials Testing the Effect of Timing of Assessment on Patient Perception

Sa1827 PREGNANCY OUTCOMES IN WOMEN WITH PSORIASIS, PSORIATIC ARTHRITIS, CROHN'S DISEASE AND ULCERATIVE COLITIS TREATED WITH USTEKINUMAB

Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study

Availability of the combination of formoterol and budesonide in the United States of America

PECAM-1 (CD31) Regulates a Hydrogen Peroxide-Activated Nonselective Cation Channel in Endothelial Cells

697 Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis

1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY

Tu1851 CORTICOSTEROID SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

Tu1879 EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION

Tu1885 EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN BIOLOGIC NAÏVE, BIOLOGIC NON-FAILURE, AND BIOLOGIC FAILURE POPULATIONS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

Tu1886 DOSE ADJUSTMENT IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI MAINTENANCE STUDY LONG-TERM EXTENSION

International Diversity in Measuring the Fair Value of Life Insurance Contracts

Tu1749 – Pharmacokinetics and Exposure-Response Relationships of Intravenously Administered Ustekinumab During Induction Treatment in Patients with Ulcerative Colitis: Results from the Unifi Induction Study

Aktive Filter

Suchergebnisse filtern